LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway. Shi W, Ling L, Li C, Wu R, et al. J Cancer Res Clin Oncol 2023;149:1295-1311.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi W, Ling L, Li C, Wu R, et al. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway. J Cancer Res Clin Oncol 2023;149:1295-1311.
PMID: 35792913